Sirius XM Q2 EPS USD 0.7
SIRI•Sirius XM reports second-quarter results
Jul 30 (Reuters) - Sirius XM Q2 net income USD 239 million.
- Q2 adjusted EBITDA USD 691 million
- Q2 free cash flow USD 593 million
- Q2 revenue USD 2,160 million vs. IBES estimate USD 2,138 million
Related News
Johnson & Johnson's Rybrevant Faspro™ (Amivantamab and Hyaluronidase-Lpuj) receives U.S. FDA priority review as potential first-in-class Egfr- and Met-targeted subcutaneous treatment for advanced head and neck cancer
JNJ•
Clearmind reports positive safety, tolerability in CMND-100 Phase I/II trial Part A dose escalation
CMND•
